A Review on the Role of MicroRNAs in Ischemic Stroke Recovery

Leila Hosseini ab, Manouchehr S. Vafaee acd, Fereshteh Farajdokht ab, Javad Mahmoudi a*

aNeurosciences Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
bDepartment of Physiology, Tabriz University of Medical Sciences, Tabriz, Iran.
cPsychiatry Research Unit, Southern Denmark Region, Odense, Denmark.
dDepartment of Nuclear Medicine, Odense University Hospital, Odense Denmark.

Correspondence
Javad Mahmoudi

Neurosciences Research Center, Tabriz University of Medical Sciences. Tabriz, Iran. Tel: +984133340730 Email: mahmoudi2044@gmail.com


Received: 2020-10-22
Accepted: 2020-12-25
DOI: 10.13183/jecns.v7i2.123

© 2020 Swedish Science Pioneers, All rights reserved.


Abstract

Ischemic stroke has become is one of the primary causes of morbidity and mortality in the world. MicroRNAs (miRNAs), small ribonucleic acids (RNAs), negatively regulate gene expression on the post-transcriptional level via promoting degradation or translational suppression of their target mRNAs. In recent years, researchers have demonstrated that miRNAs have been implicated in the pathophysiological processes contributing to ischemia-reperfusion injuries and could serve as important mediators of recovery following ischemic stroke. This review, focuses on cerebral miRNAs regulating blood-brain barrier (BBB) function, apoptosis, inflammation, and oxidative stress in stroke. It has been shown that the regulation of miRNAs expression may be a potential therapeutic target in brain ischemia recovery.

Keywords: Ischemic Stroke, MicroRNA, Neuroinflammation, Blood-Brain Barrier Integrity, Apoptosis, Oxidative Stress Burden.


Introduction

Ischemic stroke is a cerebrovascular conditions resulting from arterial occlusion in the brain and leads to high morbidity and permanent physical disabilities [1, 2]. Restoration of blood flow after ischemia leads to severe brain damage, due to excessive generation of reactive oxygen species (ROS), intraneuronal overload with Ca2+, and increased blood-brain barrier (BBB) permeability [3, 4]. Ischemic brain injury triggers several pathogenic processes, such as neuroinflammation, excitotoxicity, oxidative stress, ionic imbalance, mitochondrial dysfunction, and apoptosis, causing neuronal cell death and impaired sensory, motor, and cognitive functions [5]. Although many experimental and clinical studies have done, there is no effective therapy for treatment of ischemic insults. Hence, there is a pressure need for discover novel therapeutic steerages to reduce ischemic neuronal insults.

MicroRNAs (miRNAs), belong to class of short-length (21-23 nucleotides) noncoding single-stranded RNA molecules. They are able to bind to the 3′ untranslated region (3′UTR) of target messenger RNA (mRNA) and regulate its stabilization and protein translation [6, 7]. miRNAs are presented in the cerebral system [8] and not only have regulative role in normal physiological and cellular processes (i.e. neuronal development, synaptic plasticity, proliferation, and apoptosis), but also are involved in neurodegenerative diseases via their target genes [9-12]. It is believed that expression of the microRNAs is changed following brain ischemia, and this change can target the translation of proteins that modulate neuroinflammation, cell death, as well as oxidative stress [13]. This review article aims to concentrate on the potential role of miRNAs for treatment of ischemic stroke neuronal injuries.

MicroRNAs in Ischemic Stroke Recovery

miRNAs and Blood-Brain Barrier

Mechanisms including ROS generation, matrix metalloproteinase (MMPs) activation as well as releasing of cytokines cause vascular disruption which eventually leads to BBB dysregulation [14, 15]. Evidence shows changes in BBB integrity and function may modulate by different classes of miRNAs in a way to restore their normal activities [16, 17]. The function of the MiR-132 affects synaptic plasticity and neuronal death. Also, it is implicated in regulation of the post-stroke physiopathology such as BBB integrity [18]. In light of the experimental and clinical studies, alternations of miR-124 expression in the blood ad brain were reported in ischemic stroke. Exogenous administration miRNA-132 could attenuate brain edema and infarction volume and improve neurological outcomes of the ischemia-reperfusion (I/R) insults in mice. Also, it is not only able to maintain the BBB integrity but also inhibit the expression of MMP-9 (direct target of miR-132), degradation of VE-cadherin and tight junction proteins β-catenin [19].

Cerebral ischemia induces overexpression of miR-130a, and its inhibition regulates ischemic stroke-induced BBB permeability by targeting Homeobox A5 [20]. miR-539 [21] and miR-21 [22] can preserve BBB integrity after brain ischemia through numerous mechanisms including increased expression of tight junctions, regulation of MMP-9, and inhibition of the mitogen-activated protein kinase (MAPK) signaling. As experimental findings shows, up-regulation of miR-149-5p reduces leakage of BBB and is associated with improvement of ischemia outcome through targeting sphingosine-1-phosphate receptor 2 in pericytes [23].

miRNAs and Inflammation, Oxidative Stress, and Apoptosis

Either neuroinflammation or oxidative stress have role in development of stroke insults, eventually leading to neuronal cell injury and apoptosis [24]. Brain ischemic insults trigger the microglial activation and releasing of the inflammatory mediators [25, 26]. During ischemic brain injury, pro-inflammatory cytokines (i.e. interleukin-18 (IL-18)) and interleukin-1β (IL-1β) mediate harmful effects of the inflammatory responses. Moreover, stroke induces excessive production of free radicals and ROS which stimulate N-methyl-D-aspartic acid (NMDA) receptors to increase influx of Ca2+ into the neuronal cells and subsequent mitochondrial disruption, as well as activation of neuronal nitric oxide synthase [27]. Intraneuronal overload with Ca2+ induces the release of mitochondrial cytochrome c into cytosolic space and its subsequent binding to both apoptotic protease-activating factor-1 and procaspase- 9 and activation of caspase-9 and caspase-3 proteins, causing neuronal apoptosis [28].

Several microRNAs participate in the regulation of oxidative stress, neuroinflammatory reactions and apoptosis [28]. As findings shows, MicroRNA-9a-5p (miR-9a-5p) participates in several physiological processes such as differentiation of neural progenitor cells, neurogenesis, angiogenesis as well as dendritic growth [27, 29] . MiR-9a-5p participates in NLRP1 inflammasome-induced brain ischemic damages. As findings shows, ischemic condition downregulates miR-9a-5p expression which mediate increase of NLRP1 inflammasome proteins, cleaved caspase- 1, IL-1b, and IL-18 levels, while their levels undergo a significant reduction upon overexpression of miR-9a-5pthe in cerebral structures [30]. Zhao et al. [31] reported that overexpression of miR-424 ameliorated neuronal insults after ischemic stroke via abolishing microglial activity. It has been shown that miR-let-7c-5p has anti-inflammatory and neuroprotective effects in cerebral ischemia via preventing of the microgliosis and repression of caspase-3 protein expression [32].

MiR-22 has neuroprotective and angiogenic effects by mediating the PI3K/Akt signaling in a rat model of focal cerebral ischemia [33]. Furthermore, the upregulation of miR-22 reduces I/R induced inflammation and apoptosis [34]. Also, overexpressed miR‐31 alleviates inflammatory response and oxidative stress‐mediated neuronal injury in ischemic stroke by inhibiting JAK/STAT3 pathway through downregulation of protein kinase D production [35]. CXC motif chemokine ligand 12 (CXCL12) is produced in brain endothelium and considered as a valuable marker for prognosis of the stroke risk. Its expression increases upon brain I/R insults [36, 37]. Clinical and experimental findings shows that miR-874-3p expression was reduced in ischemic conditions [38] Overexpression of miR-874-3p suppresses CXCL12, induces angiogenesis, and inhibits inflammatory mediators through activation of the Wnt/β-catenin pathway [39]. MiR-579-3p expression has decreased in in vivo and in vitro modal of I/R injury and promoting miR-579-3p expression is associated with improvement in I/R damages and cell necrosis. MicroRNA-579-3p exhibits neuroprotective effects in brain ischemic through the modulation of neuroinflammatry reactions and apoptosis [40]. Upregulated microRNA-539-5p suppresses the neuroinflammatory responses and inhibits the development of brain I/R insults by histone deacetylase1 [41]. The expression of miR 421 was increased upon ischemic injuries. Prevention of miR-421 production through administering antagomir 2h after ischemia may have neuroprotective effects in I/R conditions via lowering oxidative stress burden and apoptosis [42]. Moreover, miR-424 and miR-124 are found to alleviate I/R damage through the reduction of apoptosis, ROS, and malondialdehyde and increasing of superoxide dismutase (SOD) and manganese SOD (MnSOD) [43] Also, miR-106b-5p and miR-23a-3p have a neuroprotective effect against cerebral ischemia by increasing the MnSOD expression and inhibiting apoptosis [44, 45]CCAAT enhancer-binding protein b (Cebpb) is involved in inflammation and the progression of brain injury after ischemic stroke [46]. Mitogen-activated protein kinase 8 (Map3k8) can activate p38, which promotes the generation of different kinds of inflammatory factors in neutrophils [47].

MicroRNA 381 3p confers protection against stroke via promoting angiogenesis and repressing the release of inflammatory factors by inhibiting Cebpb and Map3k8 [48]. MiR-195 participates in pro-apoptotic and anti-apoptotic processes. The cell stresses, including shock, hypoxia, and ROS active C-Jun N-terminal kinase (JNK), a subfamily of MAPK that plays a crucial role in apoptosis and inflammation [49]. The miR-195 overexpression protected nerve function and diminished neuronal apoptosis via inhibiting Kruppel-like factor5 (KLF5)-mediated activation of the JNK signaling pathway in rat model cerebral focal ischemia [50]. Table 1 summarized the function of microRNAs in brain ischemia.

thumblarge

Table 1.Mechanisms underlying miRNAs neuroprotective effects in ischemic stroke.

Conclusions

The miRNAs expression is dysregulated following brain ischemia, and these changes play a critical role in stroke pathophysiology. miRNAs modulation might be a new therapeutic approach in ischemic stroke (Figure 1). Further researches on miRNAs are supposed to shed new light on ischemic stroke therapy in the future.

thumblarge

Figure 1.Schematic neuroprotective function of microRNAs in ischemic stroke. BBB: blood-brain barrier.

Acknowledgment

Not applicable.

Conflict of Interest

The authors declare no conflict of interest.

References

1.  Solanki D, Kumar S, Shubha B, Lahiri U. Implications of physiologysensitive gait exercise on the lower limb electromyographic activity of hemiplegic post-stroke patients: a feasibility study in low resource settings. IEEE Journal of Translational Engineering in Health and Medicine. 2020 Jul 1;8:1-9.

2.  Ji Q, Ji Y, Peng J, Zhou X, Chen X, Zhao H, et al. Increased brainspecific MiR-9 and MiR-124 in the serum exosomes of acute ischemic stroke patients. PloS one. 2016 Sep 23;11(9):e0163645.

3.  Song, J., et al., The beneficial effect of melatonin in brain endothelial cells against oxygen-glucose deprivation followed by reperfusioninduced injury. Oxidative medicine and cellular longevity, 2014. 2014.

4.  Song J, Kang SM, Lee WT, Park KA, Lee KM, Lee JE. The beneficial effect of melatonin in brain endothelial cells against oxygen-glucose deprivation followed by reperfusion-induced injury. Oxidative medicine and cellular longevity. 2014 Oct;2014.

4.  Zhang DL, Liu X, Wang Q, Li N, Wu SH, Wang C. Downregulation of microRNA-196a attenuates ischemic brain injury in rats by directly targeting HMGA1. Eur. Rev. Med. Pharmacol. Sci. 2019 Jan 1;23:740-8.

6.  Eyileten, C., et al., MicroRNAs as diagnostic and prognostic biomarkers in ischemic stroke—a comprehensive review and bioinformatic analysis. Cells, 2018. 7(12): p. 249.

7.  Eyileten C, Wicik Z, De Rosa S, Mirowska-Guzel D, Soplinska A, Indolfi C, Jastrzebska-Kurkowska I, Czlonkowska A, Postula M. MicroRNAs as diagnostic and prognostic biomarkers in ischemic stroke—a comprehensive review and bioinformatic analysis. Cells. 2018 Dec;7(12):249.

8.  Chen Z, Yang J, Zhong J, Luo Y, Du W, Hu C, et al. MicroRNA- 193b-3p alleviates focal cerebral ischemia and reperfusion-induced injury in rats by inhibiting 5-lipoxygenase expression. Experimental neurology. 2020 May 1;327:113223.

9.  Mocellin S, Pasquali S, Pilati P. Oncomirs: from tumor biology to molecularly targeted anticancer strategies. Mini reviews in medicinal chemistry. 2009 Jan 1;9(1):70-80.

10.  Johnnidis JB, Harris MH, Wheeler RT, Stehling-Sun S, Lam MH, Kirak O, et al. Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature. 2008 Feb;451(7182):1125-9.

11.  Aumiller V, Förstemann K. Roles of microRNAs beyond development—metabolism and neural plasticity. Biochimica et Biophysica Acta (BBA)-Gene Regulatory Mechanisms. 2008 Nov 1;1779(11):692-6.

12.  Abe M, Bonini NM. MicroRNAs and neurodegeneration: role and impact. Trends in cell biology. 2013 Jan 1;23(1):30-6.

13.  Majdi A, Mahmoudi J, Sadigh-Eteghad S, Farhoudi M, Shotorbani SS. The interplay of microRNAs and post-ischemic glutamate excitotoxicity: an emergent research field in stroke medicine. Neurological Sciences. 2016 Nov;37(11):1765-71.

14.  Haley MJ, Lawrence CB. The blood–brain barrier after stroke: structural studies and the role of transcytotic vesicles. Journal of Cerebral Blood Flow & Metabolism. 2017 Feb;37(2):456-70.

15.  Keep RF, Andjelkovic AV, Xiang J, Stamatovic SM, Antonetti DA, Hua Y, Xi G. Brain endothelial cell junctions after cerebral hemorrhage: Changes, mechanisms and therapeutic targets. Journal of Cerebral Blood Flow & Metabolism. 2018 Aug;38(8):1255-75.

16.  Caballero-Garrido E, Pena-Philippides JC, Lordkipanidze T, Bragin D, Yang Y, Erhardt EB, et al. In vivo inhibition of miR-155 promotes recovery after experimental mouse stroke. Journal of Neuroscience. 2015 Sep 9;35(36):12446-64.

17.  Che F, Du H, Zhang W, Cheng Z, Tong Y. MicroRNA-132 modifies angiogenesis in patients with ischemic cerebrovascular disease by suppressing the NF‑κB and VEGF pathway. Molecular medicine reports. 2018 Feb 1;17(2):2724-30.

18.  Edbauer D, Neilson JR, Foster KA, Wang CF, Seeburg DP, Batterton MN, et al. Regulation of synaptic structure and function by FMRPassociated microRNAs miR-125b and miR-132. Neuron. 2010 Feb 11;65(3):373-84.

19.  Zuo X, Lu J, Manaenko A, Qi X, Tang J, Mei Q, et al. MicroRNA-132 attenuates cerebral injury by protecting blood-brain-barrier in MCAO mice. Experimental neurology. 2019 Jun 1;316:12-9.

20.  Wang Y, Wang MD, Xia YP, Gao Y, Zhu YY, Chen SC, et al. MicroRNA‐130a regulates cerebral ischemia–induced blood–brain barrier permeability by targeting Homeobox A5. The FASEB Journal. 2018 Feb;32(2):935-44.

21.  Fan F, Yang J, Xu Y, Guan S. MiR-539 targets MMP-9 to regulate the permeability of blood–brain barrier in ischemia/reperfusion injury of brain. Neurochemical research. 2018 Dec;43(12):2260-7.

22.  Yao X, Wang Y, Zhang D. microRNA-21 confers neuroprotection against cerebral ischemia-reperfusion injury and alleviates bloodbrain barrier disruption in rats via the MAPK signaling pathway. Journal of Molecular Neuroscience. 2018 May;65(1):43-53.

23.  Wan Y, Jin HJ, Zhu YY, Fang Z, Mao L, He Q, et al. MicroRNA‐149– 5p regulates blood–brain barrier permeability after transient middle cerebral artery occlusion in rats by targeting S1PR2 of pericytes. The FASEB Journal. 2018 Jun;32(6):3133-48.

24.  Zhang S, Wang Y, Li D, Wu J, Si W, Wu Y. Necrostatin-1 attenuates inflammatory response and improves cognitive function in chronic ischemic stroke mice. Medicines. 2016 Sep;3(3):16.

25.  Amantea D, Nappi G, Bernardi G, Bagetta G, Corasaniti MT. Postischemic brain damage: pathophysiology and role of inflammatory mediators. The FEBS journal. 2009 Jan;276(1):13-26.

26.  Bazzoni F, Rossato M, Fabbri M, Gaudiosi D, Mirolo M, Mori L, et al. Induction and regulatory function of miR-9 in human monocytes and neutrophils exposed to proinflammatory signals. Proceedings of the National Academy of Sciences. 2009 Mar 31;106(13):5282-7.

27.  Cherubini A, Ruggiero C, Polidori MC, Mecocci P. Potential markers of oxidative stress in stroke. Free Radical Biology and Medicine. 2005 Oct 1;39(7):841-52.

28.  Sun Y, Gui H, Li Q, Luo ZM, Zheng MJ, Duan JL, et al. MicroRNA‐124 protects neurons against apoptosis in cerebral ischemic stroke. CNS neuroscience & therapeutics. 2013 Oct;19(10):813-9.

29.  Fann DY, Lee SY, Manzanero S, Tang SC, Gelderblom M, Chunduri P, et al. Intravenous immunoglobulin suppresses NLRP1 and NLRP3 inflammasome-mediated neuronal death in ischemic stroke. Cell death & disease. 2013 Sep;4(9):e790-.

30.  Cao Y, Zhang H, Lu X, Wang J, Zhang X, Sun S, et al. Overexpression of MicroRNA-9a-5p ameliorates NLRP1 inflammasome-mediated ischemic injury in rats following ischemic stroke. Neuroscience. 2020 Sep 15;444:106-17.

31.  Zhao H, Wang J, Gao L, Wang R, Liu X, Gao Z, et al. MiRNA-424 protects against permanent focal cerebral ischemia injury in mice involving suppressing microglia activation. Stroke. 2013 Jun;44(6):1706-13.

32. Ni J, Wang X, Chen S, Liu H, Wang Y, Xu X, et al. MicroRNA let-7c-5p protects against cerebral ischemia injury via mechanisms involving the inhibition of microglia activation. Brain, behavior, and immunity. 2015 Oct 1;49:75-85.

33.  Wang X, Shi C, Pan H, Meng X, Ji F. MicroRNA-22 exerts its neuroprotective and angiogenic functions via regulating PI3K/Akt signaling pathway in cerebral ischemia–reperfusion rats. Journal of Neural Transmission. 2020 Jan;127(1):35-44.

34.  Yu H, Wu M, Zhao P, Huang Y, Wang W, Yin W. Neuroprotective effects of viral overexpression of microRNA‐22 in rat and cell models of cerebral ischemia‐reperfusion injury. Journal of cellular biochemistry. 2015 Feb;116(2):233-41.

35.  Li J, Lv H, Che YQ. Upregulated microRNA-31 inhibits oxidative stress-induced neuronal injury through the JAK/STAT3 pathway by binding to PKD1 in mice with ischemic stroke. Journal of cellular physiology. 2019 Sep 13;235(3):2414-28.

36.  Schutt RC, Burdick MD, Strieter RM, Mehrad B, Keeley EC. Plasma CXCL12 levels as a predictor of future stroke. Stroke. 2012 Dec;43(12):3382-6.

37.  Gu XL, Liu L, Lu XD, Liu ZR. Serum CXCL12 levels as a novel predictor of future stroke recurrence in patients with acute ischemic stroke. Molecular neurobiology. 2016 Jul;53(5):2807-14.

38.  Jiang D, Sun X, Wang S, Man H. Upregulation of miR-874-3p decreases cerebral ischemia/reperfusion injury by directly targeting BMF and BCL2L13. Biomedicine & Pharmacotherapy. 2019 Sep 1;117:108941.

39.  Xie K, Cai Y, Yang P, Du F, Wu K. Upregulating microRNA-874-3p inhibits CXCL12 expression to promote angiogenesis and suppress inflammatory response in ischemic stroke. American Journal of Physiology-Cell Physiology. 2020 Sep 1;319(3):C579-88.

40.  Jia J, Cui Y, Tan Z, Ma W, Jiang Y. MicroRNA-579-3p exerts neuroprotective effects against ischemic stroke via antiinflammation and anti-apoptosis. Neuropsychiatric Disease and Treatment. 2020;16:1229.

41.  Xue H, Liu J, Shi L, Yang H. Overexpressed microRNA-539-5p inhibits inflammatory response of neurons to impede the progression of cerebral ischemic injury by histone deacetylase 1. American Journal of Physiology-Cell Physiology. 2020 Aug 1;319(2):C381- 91.

42.  Yue Y, Zhao H, Yue Y, Zhang Y, Wei W. Downregulation of microrna-421 relieves cerebral ischemia/reperfusion injuries: involvement of anti-apoptotic and antioxidant activities. Neuromolecular medicine. 2020 Sep;22:411-9.

43. Liu P, Zhao H, Wang R, Wang P, Tao Z, Gao L, et al. MicroRNA-424 protects against focal cerebral ischemia and reperfusion injury in mice by suppressing oxidative stress. Stroke. 2015 Feb;46(2):513-9.

44.  Li P, Shen M, Gao F, Wu J, Zhang J, Teng F, et al. An antagomir to microRNA-106b-5p ameliorates cerebral ischemia and reperfusion injury in rats via inhibiting apoptosis and oxidative stress. Molecular neurobiology. 2017 May 1;54(4):2901-21.

45.  Zhao H, Tao Z, Wang R, Liu P, Yan F, Li J, et al. MicroRNA-23a-3p attenuates oxidative stress injury in a mouse model of focal cerebral ischemia-reperfusion. Brain research. 2014 Dec 10;1592:65-72.

46.  Kapadia R, Tureyen K, Bowen KK, Kalluri H, Johnson PF, Vemuganti R. Decreased brain damage and curtailed inflammation in transcription factor CCAAT/enhancer binding protein β knockout mice following transient focal cerebral ischemia. Journal of neurochemistry. 2006 Sep;98(6):1718-31.

47.  Xu D, Matsumoto ML, McKenzie BS, Zarrin AA. TPL2 kinase action and control of inflammation. Pharmacological research. 2018 Mar 1;129:188-93.

48.  Li J, Lv H, Che Y. microRNA-381-3p Confers Protection Against Ischemic Stroke Through Promoting Angiogenesis and Inhibiting Inflammation by Suppressing Cebpb and Map3k8. Cellular and molecular neurobiology. 2020 Nov;40(8):1307-19.

49.  Vahidinia Z, Tameh AA, Nejati M, Beyer C, Talaei SA, Moghadam SE, Atlasi MA. The protective effect of bone marrow mesenchymal stem cells in a rat model of ischemic stroke via reducing the C-Jun N-terminal kinase expression. Pathology-Research and Practice. 2019 Sep 1;215(9):152519.

50.  Chang L, Zhang W, Shi S, Peng Y, Wang D, Zhang L, et al. microRNA-195 attenuates neuronal apoptosis in rats with ischemic stroke through inhibiting KLF5-mediated activation of the JNK signaling pathway. Molecular Medicine. 2020 Dec;26:1-6.